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Recent advances in fluorescence microscopy allow three-dimensional analysis of HIV-1 preintegration complexes in the nuclei of
infected cells. To extend this investigation to gammaretroviruses, we engineered a fluorescent Moloney murine leukemia virus
(MLV) system consisting of MLV-integrase fused to enhanced green fluorescent protein (MLV-IN-EGFP). A comparative analy-
sis of lentiviral (HIV-1) and gammaretroviral (MLV) fluorescent complexes in the nuclei of infected cells revealed their different
spatial distributions. This research tool has the potential to achieve new insight into the nuclear biology of these retroviruses.
To complete its replication cycle, HIV-1 has to reach the nu-cleus of the infected cell, where the viral cDNA integrates itself
into the host chromatin (1). Although the integration reaction
and the targeted chromatin regions have been well characterized,
very little is known about the virus-cell interactions that take place
within the nuclear compartment.
The development of fluorescence imaging approaches to study
HIV-1 early replication steps has significantly contributed to our
knowledge of the HIV-1 life cycle. Indeed, fluorescence imaging
techniques allow the observation at the single-particle level of
HIV-1 interactions with target cell structures, preserving their
main three-dimensional (3D) structural properties. Imaging tech-
niques have revealed that HIV-1 particles (2–5) and integrated
proviruses (6), preferentially localize in the nuclear periphery,
which is consistent with the observation that peripheral chroma-
tin, especially that near the nuclear pore complexes, is favored for
HIV-1 integration (7, 8).
Here we further analyzed the 3D nuclear distribution of HIV-1
preintegration complexes (PICs) in relation to the expression of
HIV-1 integrase (IN) cofactor LEDGF/p75 (for a recent review,
see reference 9). We also developed a new tool for the detection of
fluorescentmurine leukemia virus (MLV) that allowed us to com-
pare the 3D nuclear distributions of gammaretroviral and lentivi-
ral particles.
We set out to explore the role played by LEDGF/p75 in the 3D
nuclear distribution of HIV-1 in the nucleus during the early
phases of infection. Using a technique that allows us to produce
and track fluorescentHIV-IN-enhanced greenfluorescent protein
(EGFP) PICs (2–4), we analyzed virus localization with respect to
the levels of chromatin condensation as demarcated by the ectopic
expression of histone H2B fused to red fluorescent protein (RFP)
(2). Using the same procedures we previously established (2–4),
we analyzed the localization ofHIV-IN-EGFPPICs inHeLa-H2B-
RFP cells stably silenced for LEDGF/p75 (10) (Fig. 1A). Figure 1B
shows the preferential localization of HIV-IN-EGFP PICs toward
less condensed euchromatic regions characterized by low H2B
fluorescence. Statistical analysis using the nonparametric two-
tailedKolmogorov-Smirnov test revealed no significant difference
between the distributions of HIV-1 PICs in LEDGF/p75 knock-
down and control cells (P  0.76; blue and pink curves). Con-
versely, the HIV-PIC distribution to euchromatin in both cell
lines significantly differs from the random region of interest
(ROI) distribution in the same cells (gray and black curves
from control and LEDGF/p75 knockdown cells, respectively)
(Fig. 1C). Analyses performed with a heterochromatin-specific
marker (H3K9me3) confirmed the preferential localization of
HIV-1 PICs in chromatin regions with low H3K9me3 signal
intensity (Fig. 1D), which is similar to what we previously ob-
served in wild-type cells (2). Therefore, even though LEDGF/
p75 is the main factor directing HIV-1 to specific gene-rich
regions (9, 11), it does not play a crucial role in the macrolo-
calization of HIV-1 viral complexes in the nucleus.
To confirm that the absence of an HIV-1 PIC relocalization
phenotype in LEDGF/p75 knockdown cells was not due to intrin-
sic limitations of the assay, the analysis was repeated with LEDGF/
p75 knockdown cells stably expressing CBX-LEDGF(325-530)
(12) (Fig. 1A). CBX-LEDGF(325-530) is a chimeric LEDGF/p75
molecule engineered to contain an alternative chromatin-binding
domain, CBX1, and is reported to strongly relocalize HIV-1 inte-
gration toward heterochromatin (12–14). As expected, we ob-
served that HIV-IN-EGFP PICs were randomly distributed in
these cells (Fig. 1E), confirming that the HIV-1 imaging tool cor-
rectly detects the 3D macrolocalization of HIV-1.
Therefore, even though LEDGF/p75 knockdown generates a
more random distribution of integrated proviruses (9, 15–17), in
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the absence of this IN cofactor, HIV-1 PICs preserve their local-
ization toward subnuclear regions occupied by euchromatin.
To compare the nuclear localizations of lentiviruses and gam-
maretroviruses, we developed MLV-IN-EGFP, a fluorescently la-
beled MLV. To produce fluorescently labeled viral particles, a
MoloneyMLV retroviral packaging vector, pMLV-gag-pol-EGFP,
was generated (Fig. 2A). Fusion of EGFP at theC terminus ofMLV
Pol does not impair the association between IN and BRD4 (18–
20), as demonstrated by a coimmunoprecipitation experiment
performed with 293T cells transfected with the pMLV-gag-pol-
EGFP construct (Fig. 2B). To further characterize MLV-IN-
EGFP, we tested the infectivity of the retroviral transfer vector
pBabe-Puro (21) packaged with pMLV-gag-pol-EGFP (Fig. 2C)
and pseudotyped with vesicular stomatitis virus glycoprotein
(VSV-G). These experiments showed that the infectivity of MLV-
IN-EGFP is similar to that of wild-type MLV (pBabe-Puro vector
packaged with parental phCMV-intron-gag-pol) (Fig. 2C). We
next analyzed the MLV-IN-EGFP viral complexes after infection
FIG 1 LEDGF/p75 is dispensable for the localization of HIV-1 complexes in nuclear regions occupied by euchromatin. (A)Western blot analysis of HeLa-H2B-
RFP LEDGF/p75 knockdown cells or LEDGF/p75 knockdown cells transcomplementedwithCBX-LEDGF(325-530). At the top is aWestern blot developedwith
anti-LEDGF/p75 antibodies (Bethyl Laboratories, Inc.), and at the bottom is a Western blot developed with an anti-GAPDH (glyceraldehyde 3-phosphate
dehydrogenase) antibody to control protein loading. Ctr, control. (B) Frequency distribution of H2B-RFP fluorescence intensity (F) inHIV-IN-EGFP PIC ROIs
(blue striped bars) and in randomROIs (gray bars) in LEDGF/p75 knockdown cells. (C) Distribution of cumulative probabilities plotted for HIV-IN-EGFP PIC
ROIs or random (Rnd) ROIs toward H2B-RFP fluorescence in LEDGF/p75 knockdown (LEDGF KD) or control (CTRL) cells. Reported P values were obtained
by theKolmogorov-Smirnov test (n 100). (D) Frequency distribution ofH3K9me3fluorescence intensity (F) inHIV-IN-EGFPPICROIs (red striped bars) and
in random ROIs (gray bars) in LEDGF/p75 knockdown cells. In the inset, the distributions of cumulative probabilities in PIC (red) and random (gray) ROIs are
plotted. The P value was obtained by the Kolmogorov-Smirnov test (n 100). (E) Frequency distribution of H3K9me3 fluorescence intensity (F) in PIC ROIs
(red striped bars) and in random ROIs (gray bars) in LEDGF/p75 knockdown cells expressing CBX-LEDGF(325-530). In the inset, the distributions of
cumulative probabilities in PIC (red) and random (gray) ROIs are plotted. The P value was obtained by the Kolmogorov-Smirnov test (n 100). a.u., arbitrary
units.
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of HeLa-H2B-CFP (cyan fluorescent protein) and found them to
be localized both in the cytoplasm (Fig. 2D, top) and in the nuclear
compartment, as indicated by three-axis nuclear analysis (Fig. 2D,
bottom). Twenty-four hours postinfection, an average of three
MLV-IN-EGFP complexes per nucleus were detected in viral
preparations made with an amphotropic MLV envelope (strain
4070A), while with VSV-G-pseudotyped virions, we detected an
average of 16 complexes per nucleus (Fig. 2E). Gammaretrovi-
ruses, such as MLV, need the target cell to go through mitosis in
order to complete infection (22). This has been attributed to their
inability to actively cross the nuclear envelope (22).We thus tested
the cellular localization of MLV-EGFP complexes in cells blocked
in G1 of the cell cycle by aphidicolin treatment. As expected, MLV
complexes were restricted to the cytoplasmic compartment in
FIG 2 MLV-IN-EGFP visualization system. (A) Schematic representation of the plasmid used to produceMLV-IN-EGFP particles. The construct was prepared
as follows. The 3=-terminal end of MLV pol was amplified with primers MLV pol 5= (GATCCTCGAGCTATAGAAAATTCATCACCC) and MLV pol 3=
(GATCAGATCTCCGGGGGCCTCGCGGGTTAAC) andwith the phCMV-intron-gag-pol plasmid (a gift from François-Loïc Cosset) as the template DNA and
cloned into the BglII site of plasmid pEGFP-N1 (Clontech). Next, a SnaBI-XmaI fragment encompassing the -globin intron and MLV gag-pol from phCMV-
intron-gag-pol was cloned into the SnaBI and XmaI sites of pEGFP-N1 containing the 3= end of MLV pol. (B) HEK 293T cells transfected with plasmid
pMLV-gag-pol-EGFP or control plasmid pCMV were immunoprecipitated (IP) with anti-EGFP antibodies (IP-EGFP) and analyzed by Western blotting with
anti-BRD4 antibodies (Bethyl Laboratories, Inc.) (top) or anti-EGFP antibodies (bottom). Crude lysates (input) were loaded as controls. (C) MLV-IN-EGFP
viral supernatants were produced by transfecting 5 106HEK293T cells with 20g of pBabe-Puro, 10g of pMLV-gag-pol-EGFP (or phCMV-intron-gag-pol),
and 5g of pVSV-Gwith the polyethylenimine reagent. Supernatants were collected after 48 h and filtered through a 0.45-m-pore-size filter. The infectivity of
MLV-IN-EGFPwasmeasured by counting theHeLa colonies resistant to puromycin 2 weeks postinfection with 2.87 reverse transcriptase units (RTU;measured
by PCR-enhanced reverse transcriptase (PERT) assay [3]) and approximately corresponding to a multiplicity of infection of 1. wt, wild type. (D) HeLa cells
expressingH2B-CFP and infectedwithMLV-IN-EGFP (2.87 RTU) in a 3D image (top) and a derived confocal section (bottom). (E)Numbers ofMLV-IN-EGFP
complexes in the nuclei of HeLa cells at 24 h postinfection. MLV-A and VSV-G indicate the envelopes used to produce MLV-IN-EGFP viral particles.
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aphidicolin-treated cells and nuclear complexes could not be de-
tected (Fig. 3A). As reported earlier (23), also in this case, MLV-
IN-EGFP particles associated with condensed chromatids in cells
going through mitosis were detected (Fig. 3B).
To compare the nuclear distribution ofMLV complexes to that
of HIV-1, the localization ofMLVwas assessed with respect to the
nuclear periphery and chromatin condensation. Unlike HIV-1,
the MLV complexes were homogeneously distributed in the vol-
ume spanning from the periphery to the center of the nuclei (Fig.
4A).Moreover, in cellsmarkedwith fluorescentH2B histones, the
MLV complexes did not show any preferential localization in ei-
thermore or less condensed regions of the chromatin (Fig. 4B). To
better analyze this aspect, MLV distribution was analyzed in cells
immunostained with an epigenetic marker of transcriptional re-
pression (H3K9Me3) or activation (H4K16Ac) (24). Also in this
case, we could not observe any preferential localization of MLV
with respect to either of these twomarkers (Fig. 4C and D). These
results demonstrate that while HIV-1 PICs are found mainly in
subnuclear compartments occupied by euchromatin and near the
nuclear periphery (2, 4), MLV PICs do not show any preferential
localization.
Therefore, even though both HIV-1 and MLV prefer to inte-
FIG 3 Nuclear detection of MLV complexes. (A) Confocal section obtained from HeLa cells infected with MLV-IN-EGFP particles (green spots) and immu-
nostained with lamin A/C (blue) (left image). Confocal section obtained fromHeLa cells treated with 5 M aphidicolin, infected with MLV-IN-EGFP particles
(green spots), and immunostained with lamin A/C (blue) (right image). Image analysis of fluorescent nuclear PICs is described in references 2 to 4. PIC/nucleus
values indicate the average number of nuclearMLV-IN-EGFP complexes detected in 90 cells under both conditions. (B) Visualization ofMLV-EGFP complexes
attached to chromatids (arrows).
FIG 4 3D nuclear distribution of MLV complexes. (A) Distance of intranuclear MLV complexes from lamin A/C staining. (B) Frequency distribution of
H2B-CFP fluorescence intensity (F) inMLVROIs (black striped bars) and in randomROIs (gray bars). In the inset, the distributions of cumulative probabilities
in MLV (black) and random (gray) ROIs are plotted. P  0.35 (Kolmogorov-Smirnov test; n  400). (C) Frequency distribution of H3K9me3 fluorescence
intensity (F) in MLV ROIs (black striped bars) and in random ROIs (gray bars). In the inset, the distributions of cumulative probabilities in MLV (black) and
random (gray) ROIs are plotted. P 0.33 (Kolmogorov-Smirnov test; n 270). (D) Frequency distribution ofH4K16ac fluorescence intensity (F) inMLVROIs
(black striped bars) and in random ROIs (gray bars). In the inset, the distributions of cumulative probabilities in MLV (black) and random (gray) ROIs are
plotted. P0.96 (Kolmogorov-Smirnov test; n 100). a.u., arbitrary units.
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grate within transcription units (25) associated with less con-
densed euchromatic regions, the subnuclear 3D macrodistribu-
tions of their PICs differ significantly. This difference can
probably be attributed to the different mechanisms by which
HIV-1 and MLV enter the nuclei of infected cells, i.e., either
through nuclear pore complexes (HIV-1) or during mitosis and
nuclear envelope disassembly (MLV). On the basis of this hypoth-
esis, nucleoporins or other factors might be relevant for 3D mi-
crodistribution. Alternatively, nonrandom distribution assumed
by HIV-1 PICs might simply result from their position immedi-
ately after transition through the nuclear pore complexes. In this
scenario, PICdistributionwould be determined by physical events
rather than by any specific cellular factor.
The microscopy tool reported here, by allowing the analysis of
viral PIC nuclear distribution during infection, provides a set of
information complementary to that obtained by linear sequenc-
ing, thereby shedding light on new aspects of retroviral biology.
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